NEW YORK-- Shares of some top chemicals companies were down at the close of trading:. Dow Chemical Co. fell$. 52 or 1.5 percent, to $34.10. DuPont Co. fell$. 55 or 1.0 percent, to $53.47.» Read More
Chemicals company Huntsman said Tuesday it swung to a loss in the second quarter due to a loss from discontinued operations and higher feedstock and energy costs.
Dow Chemical reported better-than-expected quarterly earnings on Thursday, as strong overseas demand offset higher energy costs and weakness in the North American housing and automotive markets.
Agrochemical company Syngenta on Thursday posted a 27% rise in net profit for the first six months and raised its outlook for the rest of the year.
DuPont, the No. 2 U.S. chemical company, Tuesday reported lower-than-expected second-quarter profit due to lower U.S. volumes coupled with higher energy and raw material costs.
Wall Street is heading for a lower opening as some weak earnings and credit market jitters outweigh positive profit reports from companies like Pepsico and Lockheed-Martin. European markets are moving lower after overnight gains in Tokyo and Hong Kong shares.
Akzo Nobel, the Dutch chemicals and industrial coatings maker, reported that net profit fell 25% to 270 million euros ($373 million) in the second quarter.
Everybody wants oil. And if you don’t want Europe, you’ve got your head on backwards, Cramer said. This stock covers both.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
The chemicals sector is enjoying a bull run, but there’s some M&A action to be had as well. Cramer says the next most likely target is Nova Chemicals.
As BASF's business gets less and less cyclical, the earnings get more consistent. That means the stock will pull a premium price on Wall Street.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
Chemical and plastics maker Basell said on Tuesday it would buy Lyondell Chemical in a deal valued at about $12.14 billion, giving Basell access to a key raw material and Lyondell's refining capacity.
Paint and chemicals maker Rohm & Haas said after U.S. markets closed Monday that its board approved a $2 billion stock buyback plan that will be executed in two stages.
Chemicals maker Huntsman agreed to a $6.5 billion buyout offer from an affiliate of Apollo Management on Thursday, terminating an earlier deal to sell itself at a lower price to a Dutch company.
Apollo Management raised its offer for chemical company Huntsman by 2.8% to $6.5 billion Monday, widening the premium over rival suitor Basell.
A group of investors led by private equity firm CVC Capital Partners said Monday it bid 1.5 billioneuros ($2 billion) for chemicals distributor Univar with approval from Univar's boards.
U.S. chemical company Huntsman said Friday the $6 billion buyout offer from Apollo Management's Hexion Specialty Chemicals is superior to the previously accepted deal offered by Basell.
A bounce back in takeover activity, including Blackstone's bold $26 billion bid for Hilton, is giving strength to stock futures ahead of the opening on the second leg of this holiday-shortened week.
U.S. private equity firm Apollo Management unveiled a $6 billion bid proposal for Huntsman on Wednesday, 8% higher than a deal accepted by the U.S. chemical company last week.
Chemicals maker Basell said Tuesday it has agreed to buy U.S. chemical company Huntsman for $5.6 billion excluding debt, in a bid to strengthen its position as a global chemicals group.
Shares in Standard Chartered fell 1.2% Wednesday despite an upbeat trading statement from the global bank, as investors cashed in on the stock's recent strong performance, according to Keefe, Bruyette and Woods.
German drugs and chemicals group Bayer raised its profit outlook on strong sales of drugs such as multiple sclerosis treatment Betaseron and higher savings from the integration of Schering, sending its shares higher.